Antiproliferative and apoptotic activities of novel curcumin analogs in human liver cancer cell lines
-
摘要: 采用MTT法对姜黄素结构衍生物(CCM系列化合物)进行抗人肝癌细胞Bel-7402和SMMC-7721活性筛选;利用流式细胞技术和荧光显微镜检测SMMC-7721细胞凋亡及周期分布;采用Western-Blot方法检测SMMC-7721中蛋白caspase-3和剪切后p17的表达.结果表明,化合物CCM-5和CCM-14抗肿瘤活性较好,其对SMMC-7721细胞的凋亡作用呈剂量依赖性,且凋亡率与阴性对照组相比有显著差异(P0.01);化合物浓度增高时,G0/G1期细胞减少,S期以及G2/M期细胞增加,凋亡峰SubG1峰增大;两个化合物均可增强caspase-3的表达,随着浓度的提高,caspase-3的表达趋势减弱,而剪切形式p17亚基表达量逐渐提高.因此,姜黄素结构衍生物CCM-5和CCM-14能抑制人肝癌细胞SMMC-7721细胞的增殖,促进凋亡,其作用机制可能与化合物诱导caspase-3活性的增强有关.
-
关键词:
- 姜黄素结构衍生物 /
- Bel-7402细胞 /
- SMMC-7721细胞 /
- 细胞凋亡 /
- 细胞周期 /
- Caspase-3
Abstract: Antiproliverative and apoptotic activities of the novel curcumin analogs (CCM series) against human liver carcinoma Bal-7402 and SMMC-7721 cells were investigated by MTT assay. The cell cycle distribution and apoptosis of SMMC-7721 cells induced by CCM-5 and CCM-14 were analyzed using flow cytometry. The expressions of caspase-3 and its activated form p17 in SMMC-7721 cells were further determined by western blot. CCM-5 and CCM-14 exhibited, in a concentration-dependent manner, the stronger antiproliferative role than those of curcumin and the other CCM compounds. Their apoptotic effects on the SMMC-7721 cells were also found to be significantly elevated as compared with the control group (P0.01). Cell cycle distribution appeared that, as the concentrations of the compounds increased in SMMC-7721 cells, the G0/G1 phase cells decreased while the S phase and the G2/M phase cells, and the SubG1 peak increased. Furthermore, both CCM-5 and CCM-14 could activate caspase-3 expression in the SMMC-7721 cells. Collectively, our data suggest that CCM-5 and CCM-14 can restrain proliferation and promote apoptosis in SMMC-7721 cell, and the molecular mechanism underlying these actions against the cancer cells of the compounds may involve in the activation of caspase-3.-
Key words:
- curcumin analogs /
- Bel-7402 cells /
- SMMC-7721 cells /
- apoptosis /
- cell cycle /
- caspase-3
-
[1] [1]BUSH J A, CHEUNG K J JR, LI G. Curcumin induces apoptosis in human melanoma cells through a FAS receptor/caspase-8 pathway independent of p53[J]. Exp Cell Res, 2001, 271(2): 305-314.[2]PAN M H, CHANG W L, LIN-SHIAU S Y, et al. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells[J]. J Agric Food Chem, 2001, 49(3): 1464-1474.[3]肖红艳,温玉库.姜黄素抗癌作用及机制研究进展[J].社区医学杂志, 2006, 12(4): 40-42.[4]陆鹏,童强松,姜凤超,等. 姜黄素前体药物的合成及其体外抗肿瘤活性研究[J].中国药理学通报,2006, 22(3): 321-324.[5]韦星船,杜志云,涂增清,等. 姜黄素衍生物与类似物的构效关系研究进展[J].化学研究与应用, 2010, 22(5): 527-538.[6]张磊,李杰,陈国良.姜黄素衍生物生物活性的研究进展[J].沈阳药科大学学报,2008, 25(4): 331-336.[7]DENG X K, YIN W, LI W D, et al. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism[J]. J Ethnopharmacol, 2006, 106(2): 179-186.[8]GAO W, LAM W, ZHONG S, et al. Novel mode of action of tylophorine analogs as antitumor compounds[J]. Cancer Res, 2004, 64(2): 678-688.[9]ZhANG H N, YU C X, ZhANG P J, et al. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP[J]. Acta Pharmacol Sin, 2007, 28(3): 423-430.[10] KOIKE K, TAKAK A, TATSUKAWA M, et al. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines[J]. Int J Oncol, 2006, 29(5): 1253-1261.[11] KHAFIF A, SCHANTZ S P, CHOU T C, et al. Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells[J]. Carcinogenesis, 1998, 19(3): 419-424.[12] AOKI H, TAKADA Y, KONDO S, et al. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways[J]. Mol Pharmacol, 2007, 72(1): 29-39.[13] LEV-ARI S, STARR A, VEXLER A, et al. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity[J]. Anticancer Res, 2006, 26(6B): 4423-4430.[14] PARK C, KIM G Y, KIM G D, et al. Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells[J]. Oncol Rep, 2006, 15(5): 1225-1231.[15] ROBERTSON G S, CROCKER S J, NICHOLSON D W, et al. Neuroprotection by the inhibition of apoptosis[J]. Brain Pathol, 2000, 10(2): 283-292.[16] PAL S, CHOUDHURI T, CHATTOPADHYAY S, et al. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells[J]. Biochem Biophys Res Commun, 2001, 288(3): 658-665.[17] SHANKAR S, CHEN Q, SARVA K, et al. Curcumin enhances the apoptosis-inducing potential of TRAIL in 〖JP2〗prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis[J]. J Mol Signal, 2007(2):10.〖JP〗[18] VOLATE S R, DAVENPORT D M, MUGA S J, et al. Modulation of aberrant crypt foci and apoptosis by dietary 〖JP2〗herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin)[J]. Carcinogenesis, 2005, 26(8): 1450-1456.〖JP〗[19] SU C C, LIN J G, LI T M, et al. Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3[J]. Anticancer Res, 2006, 26(6B): 4379-4389.[20] TAN T W, TSAI H R, LU H F, et al. Curcumin-induced cell cycle arrest and apoptosis in human acute 〖JP2〗promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation[J]. Anticancer Res, 2006, 26(6B): 4361-4371.〖JP〗[21] ASHKENAZI A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily[J]. Nat Rev Cancer, 2002, 2(6): 420-430.[22] FULAD S, DEBATIN K M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy[J]. Oncogene, 2006, 25(34): 4798-4811.[23] WANG J, CHUN H J, WONG W, et al. Caspase-10 is an initiator caspase in death receptor signaling[J]. Proc Natl Acad Sci U S A, 2001, 98(24): 13884-13888.[24] MORAGODA L, JASZEWSKI R, MAJUMDAR A P. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells[J]. Anticancer Res, 2001, 21(2A): 873-878.[25] LOGAN-SMITH M J, EAST J M, LEE A G. Evidence for a global inhibitor-induced conformation change on the Ca(2+)-ATPase of sarcoplasmic reticulum from paired inhibitor studies[J]. Biochemistry, 2002, 41(8): 2869-2875.[26] LOGAN-SMITH M J, LOCKYER P J, EAST J M, et al. Curcumin, a molecule that inhibits the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2+[J]. J Biol Chem, 2001, 276(50): 46905-46911.[27] PAE H O, JEONG S O, JEONG G S, et al. Curcumin induces pro-apoptotic endoplasmic reticulum stress in human leukemia HL-60 cells[J]. Biochem Biophys Res Commun, 2007, 353(4): 1040-1045.[28] BAKHSHI J, WEINSTEIN L, POKSAY K S, et al. Coupling endoplasmic reticulum stress to the cell death program in mouse melanoma cells: effect of curcumin[J]. Apoptosis, 2008, 13(7): 904-914.[29] MARIN Y E, WALL B A, WANG S, et al. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells[J]. Melanoma Res, 2007, 17(5): 274-283.[30] AGGARWAL S, TAKADA Y, SINGH S, et al. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling[J]. Int J Cancer, 2004, 111(5): 679-692.[31] LIU C A, WAMG M J, CHI C W, et al. Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis[J]. Oncogene, 2004, 23(54): 8731-8742.[32] TOMITA M, KAWAKAMI H, UCHIHARA J N, et al. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells[J]. Int J Cancer, 2006, 118(3): 765-772.[33] HUSSAIN A R, Al-RASHEED M, MANOGARAN P S, et al. Curcumin induces apoptosis via inhibition of PI3'-kinase/AKT pathway in acute T cell leukemias[J]. Apoptosis, 2006, 11(2): 245-254.[34] GURURAJAN M, DASU T, SHAHIDAIN S, et al. Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth[J]. J Immunol, 2007, 178(1): 111-121.[35] BEEVERS C S, LI F, LIU L, et al. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells[J]. Int J Cancer, 2006, 119(4): 757-764.[36] SQUIRES M S, HUDSON E A, HOWELLS L, et al. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells[J]. Biochem Pharmacol, 2003, 65(3): 361-376.[37] HAY N, SONENBERG N. Upstream and downstream of mTOR[J]. Genes Dev, 2004, 18(16): 1926-1945.[38] DEAN M, FOJO T, BATES S. Tumor stem cells and drug resistance[J]. Nat Rev Cancer, 2005, 5(4): 275-284.
点击查看大图
计量
- 文章访问数: 2701
- HTML全文浏览量: 27
- PDF下载量: 3947
- 被引次数: 0